Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphoma
A simple PET scan measurement at diagnosis helps predict which follicular lymphoma patients will progress early, enabling more personalized upfront treatment decisions.
In 119 newly diagnosed follicular lymphoma patients, a PET-derived SUVmax cutoff of 14.5 independently identified those with inferior PFS and higher risk of early progression (POD24), a well-established high-risk marker in FL. Baseline SUVmax may complement FLIPI and PRIMA-PI scoring as a readily available metabolic risk stratification tool in routine clinical practice.
What the study was
- Study design
- Retrospective single-center cohort study
- Population
- Newly diagnosed follicular lymphoma patients undergoing baseline FDG PET/CT (n=119)
- Sample size
- 119
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Annals of Nuclear Medicine
Why it surfaced
PET SUVmax is widely available; independent prognostic value for POD24 in FL is clinically actionable for risk stratification; retrospective single-center limits generalizability.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.